LinkedIn Icon
April 22-25, 2019 | Boston, MA

Why 2019?

Non-Invasive Biomarkers Deep Dive

Join the full seminar day dedicated to benchmarking and sharing the most innovative case studies set to unlock the next arsenal of NASH candidates. Chaired by Jay Chuang (NASH, Fibrotic Diseases, Biomarker Sciences & Research Scientist at Gilead) this focused seminar benchmarks the very latest from NIMBLE, LITMUS and innovations within imaging and serum biomarkers to better inform your biomarker related strategies and support clinical program success.

Commercial Leaders Day

Hear from marketing and commercial development leads as they share perspectives on strategizing considerations for commercialization, navigating market development, and building investor confidence in the crowded NASH landscape. Chaired by Allison Capone (Global Strategic Marketing for NASH at Intercept), be part of the discussions taking place within this exclusively commercial stream and map out the next step of your business development plan in NASH.

Patient’s Insight Evening

Join us for an evening of networking and NASH patient speakers. Establish connections early on, contextualize conversations before the main sessions or just relax and enjoy the atmosphere. We’re excited to host you all and celebrate the progress of drug development in the last 12 months.